<?xml version="1.0" encoding="UTF-8"?>
<p id="par0015">So far, there are very limited data from controlled human trials of hydroxyl-chloroquine treatment for SARS-1 or COVID-19. Gautret et al. 
 <xref rid="bib0170" ref-type="bibr">[11]</xref> treated 26 patients infected with SARS-CoV-2 with hydroxy-chloroquine and showed a decreased viral load in nasopharyngeal swabs; however, this study was limited by the small patient numbers and high dropout rate.
</p>
